Active Pharmaceutical Ingredients(API) Market Report

China Active Pharmaceutical Ingredients(API) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 29, 2023
  • PAGES：230
  • REPORT CODE：GMM1765896
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Active Pharmaceutical Ingredients(API) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Lupin

    • AbbVie

    • Shandong Lukang Pharmaceutical

    • Sanofi

    • Haerbin Pharmaceutical Group

    • Sun Pharmaceutical Industries

    • Pfizer

    • Bayer

    • Johnson & Johnson

    • Boehringer Ingelheim

    • North China Pharmaceutical Group

    • Teva Pharmaceutical

    • Merck & Co

    • GlaxoSmithKline

    • Hisun Pharmacy

    • Lonza Group

    • Huahai Pharmaceutical

    • Biocon

    • Eli Lilly and Company

    • Jiangsu Hengrui Medicine

    • Novartis International

    • DSM

    By Type:

    • Biotech APIs

    • Synthetic APIs

    By Application:

    • Endocrinology

    • Cardiovascular Disease

    • Diabetes

    • CNS and Neurological Disorders

    • Oncology

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Active Pharmaceutical Ingredients(API) Market Overview 2018-2029

    • 1.1 China Active Pharmaceutical Ingredients(API) Industry Development Overview

    • 1.2 China Active Pharmaceutical Ingredients(API) Industry Development History

    • 1.3 China Active Pharmaceutical Ingredients(API) Industry Market Size (2018-2029)

    • 1.4 China Active Pharmaceutical Ingredients(API) Market Analysis by Type from Production Side

      • 1.4.1 China Active Pharmaceutical Ingredients(API) Production Volume, Production Value and Growth Rate of Biotech APIs (2018-2029)

      • 1.4.2 China Active Pharmaceutical Ingredients(API) Production Volume, Production Value and Growth Rate of Synthetic APIs (2018-2029)

    • 1.5 China Active Pharmaceutical Ingredients(API) Market Analysis by Application from Consumption End

      • 1.5.1 China Active Pharmaceutical Ingredients(API) Sales Volume, Sales Value and Growth Rate of Endocrinology (2018-2029)

      • 1.5.2 China Active Pharmaceutical Ingredients(API) Sales Volume, Sales Value and Growth Rate of Cardiovascular Disease (2018-2029)

      • 1.5.3 China Active Pharmaceutical Ingredients(API) Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

      • 1.5.4 China Active Pharmaceutical Ingredients(API) Sales Volume, Sales Value and Growth Rate of CNS and Neurological Disorders (2018-2029)

      • 1.5.5 China Active Pharmaceutical Ingredients(API) Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • 1.6 China Active Pharmaceutical Ingredients(API) Market Analysis by Region

      • 1.6.1 North China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Active Pharmaceutical Ingredients(API) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Active Pharmaceutical Ingredients(API) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Active Pharmaceutical Ingredients(API) Market Status and Competition Analysis in 2023

      • 2.2.3 China Active Pharmaceutical Ingredients(API) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Active Pharmaceutical Ingredients(API) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Active Pharmaceutical Ingredients(API) Industry Development

    Chapter 3 Active Pharmaceutical Ingredients(API)Industry Chain Analysis

    • 3.1 Active Pharmaceutical Ingredients(API) Industry Chain

    • 3.2 Active Pharmaceutical Ingredients(API) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Active Pharmaceutical Ingredients(API) Market

    • 3.3 Active Pharmaceutical Ingredients(API) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Active Pharmaceutical Ingredients(API) Market

    Chapter 4 China Active Pharmaceutical Ingredients(API) Market, by Type

    • 4.1 China Active Pharmaceutical Ingredients(API) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Active Pharmaceutical Ingredients(API) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Active Pharmaceutical Ingredients(API) Production Volume and Growth Rate, by Type

      • 4.5.1 China Active Pharmaceutical Ingredients(API) Production Volume and Growth Rate of Biotech APIs

      • 4.5.2 China Active Pharmaceutical Ingredients(API) Production Volume and Growth Rate of Synthetic APIs

    Chapter 5 China Active Pharmaceutical Ingredients(API) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Active Pharmaceutical Ingredients(API) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate, by Application

      • 5.5.1 China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate of Endocrinology

      • 5.5.2 China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate of Cardiovascular Disease

      • 5.5.3 China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate of Diabetes

      • 5.5.4 China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate of CNS and Neurological Disorders

      • 5.5.5 China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate of Oncology

    Chapter 6 China Active Pharmaceutical Ingredients(API) Market, by Region

    • 6.1 China Active Pharmaceutical Ingredients(API) Production Volume and Production Value, by Region

    • 6.2 China Active Pharmaceutical Ingredients(API) Sales Volume and Sales Value, by Region

    Chapter 7 North China Active Pharmaceutical Ingredients(API) Market Analysis

    • 7.1 North China Active Pharmaceutical Ingredients(API) Market, by Type

    • 7.2 North China Active Pharmaceutical Ingredients(API) Market, by Application

    Chapter 8 Central China Active Pharmaceutical Ingredients(API) Market Analysis

    • 8.1 Central China Active Pharmaceutical Ingredients(API) Market, by Type

    • 8.2 Central China Active Pharmaceutical Ingredients(API) Market, by Application

    Chapter 9 South China Active Pharmaceutical Ingredients(API) Market Analysis

    • 9.1 South China Active Pharmaceutical Ingredients(API) Market, by Type

    • 9.2 South China Active Pharmaceutical Ingredients(API) Market, by Application

    Chapter 10 East China Active Pharmaceutical Ingredients(API) Market Analysis

    • 10.1 East China Active Pharmaceutical Ingredients(API) Market, by Type

    • 10.2 East China Active Pharmaceutical Ingredients(API) Market, by Application

    Chapter 11 Northeast China Active Pharmaceutical Ingredients(API) Market Analysis

    • 11.1 Northeast China Active Pharmaceutical Ingredients(API) Market, by Type

    • 11.2 Northeast China Active Pharmaceutical Ingredients(API) Market, by Application

    Chapter 12 Southwest China Active Pharmaceutical Ingredients(API) Market Analysis

    • 12.1 Southwest China Active Pharmaceutical Ingredients(API) Market, by Type

    • 12.2 Southwest China Active Pharmaceutical Ingredients(API) Market, by Application

    Chapter 13 Northwest China Active Pharmaceutical Ingredients(API) Market Analysis

    • 13.1 Northwest China Active Pharmaceutical Ingredients(API) Market, by Type

    • 13.2 Northwest China Active Pharmaceutical Ingredients(API) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Lupin

        • 14.1.1 Lupin Company Profile

        • 14.1.2 Lupin Active Pharmaceutical Ingredients(API) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 AbbVie

        • 14.2.1 AbbVie Company Profile

        • 14.2.2 AbbVie Active Pharmaceutical Ingredients(API) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Shandong Lukang Pharmaceutical

        • 14.3.1 Shandong Lukang Pharmaceutical Company Profile

        • 14.3.2 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients(API) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sanofi

        • 14.4.1 Sanofi Company Profile

        • 14.4.2 Sanofi Active Pharmaceutical Ingredients(API) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Haerbin Pharmaceutical Group

        • 14.5.1 Haerbin Pharmaceutical Group Company Profile

        • 14.5.2 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients(API) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sun Pharmaceutical Industries

        • 14.6.1 Sun Pharmaceutical Industries Company Profile

        • 14.6.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients(API) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pfizer

        • 14.7.1 Pfizer Company Profile

        • 14.7.2 Pfizer Active Pharmaceutical Ingredients(API) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Bayer

        • 14.8.1 Bayer Company Profile

        • 14.8.2 Bayer Active Pharmaceutical Ingredients(API) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Johnson & Johnson

        • 14.9.1 Johnson & Johnson Company Profile

        • 14.9.2 Johnson & Johnson Active Pharmaceutical Ingredients(API) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Boehringer Ingelheim

        • 14.10.1 Boehringer Ingelheim Company Profile

        • 14.10.2 Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 North China Pharmaceutical Group

        • 14.11.1 North China Pharmaceutical Group Company Profile

        • 14.11.2 North China Pharmaceutical Group Active Pharmaceutical Ingredients(API) Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Teva Pharmaceutical

        • 14.12.1 Teva Pharmaceutical Company Profile

        • 14.12.2 Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Merck & Co

        • 14.13.1 Merck & Co Company Profile

        • 14.13.2 Merck & Co Active Pharmaceutical Ingredients(API) Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 GlaxoSmithKline

        • 14.14.1 GlaxoSmithKline Company Profile

        • 14.14.2 GlaxoSmithKline Active Pharmaceutical Ingredients(API) Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Hisun Pharmacy

        • 14.15.1 Hisun Pharmacy Company Profile

        • 14.15.2 Hisun Pharmacy Active Pharmaceutical Ingredients(API) Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Lonza Group

        • 14.16.1 Lonza Group Company Profile

        • 14.16.2 Lonza Group Active Pharmaceutical Ingredients(API) Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Huahai Pharmaceutical

        • 14.17.1 Huahai Pharmaceutical Company Profile

        • 14.17.2 Huahai Pharmaceutical Active Pharmaceutical Ingredients(API) Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Biocon

        • 14.18.1 Biocon Company Profile

        • 14.18.2 Biocon Active Pharmaceutical Ingredients(API) Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Eli Lilly and Company

        • 14.19.1 Eli Lilly and Company Company Profile

        • 14.19.2 Eli Lilly and Company Active Pharmaceutical Ingredients(API) Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Jiangsu Hengrui Medicine

        • 14.20.1 Jiangsu Hengrui Medicine Company Profile

        • 14.20.2 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients(API) Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 Novartis International

        • 14.21.1 Novartis International Company Profile

        • 14.21.2 Novartis International Active Pharmaceutical Ingredients(API) Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 DSM

        • 14.22.1 DSM Company Profile

        • 14.22.2 DSM Active Pharmaceutical Ingredients(API) Market Performance

        • 14.22.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Active Pharmaceutical Ingredients(API) Industry Research Conclusions

    • 15.2 Active Pharmaceutical Ingredients(API) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Active Pharmaceutical Ingredients(API) Industry Market Size (2018-2029)

    • Figure China Active Pharmaceutical Ingredients(API) Production Volume, Production Value and Growth Rate of Biotech APIs (2018-2029)

    • Figure China Active Pharmaceutical Ingredients(API) Production Volume, Production Value and Growth Rate of Synthetic APIs (2018-2029)

    • Figure China Active Pharmaceutical Ingredients(API) Sales Volume, Sales Value and Growth Rate of Endocrinology (2018-2029)

    • Figure China Active Pharmaceutical Ingredients(API) Sales Volume, Sales Value and Growth Rate of Cardiovascular Disease (2018-2029)

    • Figure China Active Pharmaceutical Ingredients(API) Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

    • Figure China Active Pharmaceutical Ingredients(API) Sales Volume, Sales Value and Growth Rate of CNS and Neurological Disorders (2018-2029)

    • Figure China Active Pharmaceutical Ingredients(API) Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure North China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

    • Figure Central China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

    • Figure South China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

    • Figure East China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate from 2018-2029

    • Figure Active Pharmaceutical Ingredients(API) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Active Pharmaceutical Ingredients(API) Market Share by Type in 2018

    • Figure China Active Pharmaceutical Ingredients(API) Market Share by Type in 2023

    • Figure China Active Pharmaceutical Ingredients(API) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Active Pharmaceutical Ingredients(API) Production Volume and Growth Rate of Biotech APIs (2018-2023)

    • Figure China Active Pharmaceutical Ingredients(API) Production Volume and Growth Rate of Synthetic APIs (2018-2023)

    • Figure China Active Pharmaceutical Ingredients(API) Market Share by Application in 2018

    • Figure China Active Pharmaceutical Ingredients(API) Market Share by Application in 2023

    • Figure China Active Pharmaceutical Ingredients(API) Total Market Size and Growth Rate from Consumption End

    • Figure China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate of Endocrinology (2018-2023)

    • Figure China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate of Cardiovascular Disease (2018-2023)

    • Figure China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate of Diabetes (2018-2023)

    • Figure China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate of CNS and Neurological Disorders (2018-2023)

    • Figure China Active Pharmaceutical Ingredients(API) Market Size and Growth Rate of Oncology (2018-2023)

    • Table China Active Pharmaceutical Ingredients(API) Production Volume by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients(API) Production Volume Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredients(API) Production Volume Share by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients(API) Production Value by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients(API) Production Value Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredients(API) Production Value Share by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients(API) Sales Volume by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients(API) Sales Volume Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredients(API) Sales Volume Share by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients(API) Sales Value by Region (2018-2023)

    • Table China Active Pharmaceutical Ingredients(API) Sales Value Share by Region (2018-2023)

    • Figure China Active Pharmaceutical Ingredients(API) Sales Value Share by Region (2018-2023)

    • Table North China Active Pharmaceutical Ingredients(API) Production Volume by Type (2018-2023)

    • Table North China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Figure North China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Table North China Active Pharmaceutical Ingredients(API) Sales Volume by Application (2018-2023)

    • Table North China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Figure North China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Table Central China Active Pharmaceutical Ingredients(API) Production Volume by Type (2018-2023)

    • Table Central China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Figure Central China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Table Central China Active Pharmaceutical Ingredients(API) Sales Volume by Application (2018-2023)

    • Table Central China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Figure Central China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Table South China Active Pharmaceutical Ingredients(API) Production Volume by Type (2018-2023)

    • Table South China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Figure South China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Table South China Active Pharmaceutical Ingredients(API) Sales Volume by Application (2018-2023)

    • Table South China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Figure South China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Table East China Active Pharmaceutical Ingredients(API) Production Volume by Type (2018-2023)

    • Table East China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Figure East China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Table East China Active Pharmaceutical Ingredients(API) Sales Volume by Application (2018-2023)

    • Table East China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Figure East China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredients(API) Production Volume by Type (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredients(API) Sales Volume by Application (2018-2023)

    • Table Northeast China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredients(API) Production Volume by Type (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredients(API) Sales Volume by Application (2018-2023)

    • Table Southwest China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredients(API) Production Volume by Type (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Active Pharmaceutical Ingredients(API) Production Volume Share by Type (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredients(API) Sales Volume by Application (2018-2023)

    • Table Northwest China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Active Pharmaceutical Ingredients(API) Sales Volume Share by Application (2018-2023)

    • Table Lupin Company Profile

    • Table Lupin Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Shandong Lukang Pharmaceutical Company Profile

    • Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Haerbin Pharmaceutical Group Company Profile

    • Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Sun Pharmaceutical Industries Company Profile

    • Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table North China Pharmaceutical Group Company Profile

    • Table North China Pharmaceutical Group Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Company Profile

    • Table Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Merck & Co Company Profile

    • Table Merck & Co Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Hisun Pharmacy Company Profile

    • Table Hisun Pharmacy Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Lonza Group Company Profile

    • Table Lonza Group Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Huahai Pharmaceutical Company Profile

    • Table Huahai Pharmaceutical Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Jiangsu Hengrui Medicine Company Profile

    • Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table Novartis International Company Profile

    • Table Novartis International Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)

    • Table DSM Company Profile

    • Table DSM Active Pharmaceutical Ingredients(API) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US